Correction: Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress (PLoS ONE (2011) 6:1 (e15865) DOI: 10.1371/journal.pone.0015865);Survivin mutant protects differentiated dopaminergic SK-N-SH cells against oxidative stress

PLoS ONE

Volumn 6, Issue 1, 2011, Pages

  Baratchi, Sara ^a   Kanwar, Rupinder K ^a   Kanwar, Jagat R ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 9; CATALASE; CYCLIN D1; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROGEN PEROXIDE; MUTANT PROTEIN; NEUROPROTECTIVE AGENT; SUPEROXIDE DISMUTASE; SURR9 C84A; SURVIVIN; UNCLASSIFIED DRUG; ANTIOXIDANT; BIRC5 PROTEIN, HUMAN; DOPAMINE; INHIBITOR OF APOPTOSIS PROTEIN;

ANTIOXIDANT ACTIVITY; ARTICLE; CELL STRESS; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; NERVE CELL DIFFERENTIATION; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROPROTECTION; NEUROTOXICITY; OXIDATIVE STRESS; PROTEIN EXPRESSION; CELL DEATH; DRUG EFFECT; GENETICS; METABOLISM; NERVE CELL; TUMOR CELL LINE;

ANTIOXIDANTS; CELL DEATH; CELL LINE, TUMOR; DOPAMINE; HUMANS; HYDROGEN PEROXIDE; INHIBITOR OF APOPTOSIS PROTEINS; MUTANT PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS;

EID: 79251555929     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194587     Document Type: Erratum

References (33)

1. Barone P (2010) Neurotransmission in Parkinson's disease: beyond dopamine. European Journal of Neurology 17: 364-376.
2. Jenner P (2003) Oxidative stress in Parkinson's disease. Annals of Neurology 53: S26-S36.
3. Kanwar JR, Kanwar RK, Burrow H, Baratchi S (2009) Recent Advances on the Roles of NO in Cancer and Chronic Inflammatory Disorders. Current Medicinal Chemistry 16: 2373-2394.
4. Lotharius J, Brundin P (2002) Pathogenesis of Parkinson's disease: Dopamine, vesicles and alpha-synuclein. Nature Reviews Neuroscience 3: 932-942.
5. Graham DG (1978) Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Molecular Pharmacology 14: 633-643.
6. Mattson MP, Liu D (2002) Energetics and oxidative stress in synaptic plasticity and neurodegenerative disorders. Neuromolecular Medicine 2: 215-231.
7. Xu DG, Crocker SJ, Doucet JP, StJean M, Tamai K, et al. (1997) Elevation of neuronal expression of NAIP reduces ischemic damage in the rat hippocampus. Nature Medicine 3: 997-1004.
8. Perrelet D, Ferri A, MacKenzie AE, Smith GM, Korneluk RG, et al. (2000) IAP family proteins delay motoneuron cell death in vivo. European Journal of Neuroscience 12: 2059-2067.
9. Donnini S, Solito R, Monti M, Balduini W, Carloni S, et al. (2009) Prevention of ischemic brain injury by treatment with the membrane penetrating apoptosis inhibitor, TAT-BH4. Cell Cycle 8: 1271-1278.
10. Kanwar JR, Shen WP, Kanwar RK, Berg RW, Krissansen GW (2001) Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy. Journal of the National Cancer Institute 93: 1541-1552.
11. Kanwar JR, Shen WP, Kanwar RK, Sun XY, Berg RW, et al. (2004) Survivin antagonists and antisense HIF-1 alpha stimulate the generation of tumor-specific CTLs: May be beneficial for the treatment of large lymphomas. Cancer Gene Therapy 11: 853.
12. Kanwar RK, Cheung CHA, Chang JY, Kanwar JR (2010) Recent Advances in Anti-Survivin Treatments for Cancer. Current Medicinal Chemistry 17: 1509-1515.
13. Makrantoni V, Stark MJR (2009) Efficient Chromosome Biorientation and the Tension Checkpoint in Saccharomyces cerevisiae both Require Bir1. Molecular and Cellular Biology 29: 4552-4562.
14. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, et al. (2003) HBXIP functions as a cofactor of survivin in apoptosis suppression. Embo Journal 22: 2729-2740.
15. Dohi T, Xia F, Altieri DC (2007) Compartmentalized phosphorylation of IAP by protein kinase A regulates cytoprotection. Molecular Cell 27: 17-28.
16. Baratchi S, Kanwar RK, Kanwar JR (2010) Survivin: A target from brain cancer to neurodegenerative disease. Crit Rev Biochem Mol Biol 45: 535-554.
17. Baratchi S, Kanwar RK, Kanwar JR (2010) Novel Survivin Mutant Protects Differentiated SK-N-SH Human Neuroblastoma Cells from Activated T-cell Neurotoxicity. Journal of neuroimmunology [Epub ahead of print].
18. Chang PA, Chen R, Wu YJ (2005) Reduction of neuropathy target esterase does not affect neuronal differentiation, but moderate expression induces neuronal differentiation in human neuroblastoma (SK-N-SH) cell line. Molecular Brain Research 141: 30-38.
19. Cheung CHA, Kanwar J, Krissansen GW (2006) A cell-permeable dominantnegative Survivin protein as a tool to understand how Survivin maintains tumour cell survival. Ejc Supplements 4: 488.
20. Baratchi S, Kanwar RK, Chun HAC, Kanwar JR (2010) Proliferective and protective effects of SurR9-C84A on differentiated neuronal cells. Journal of NeuroImmunology 227: 120-132.
21. Herrup K, Yang Y (2007) Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nature Reviews Neuroscience 8: 368-378.
22. Burns KA, Ayoub AE, Breunig JJ, Adhami F, Weng WL, et al. (2007) Nestin- CreER mice reveal DNA synthesis by nonapoptotic neurons following cerebral ischemia-hypoxia. Cerebral Cortex 17: 2585-2592.
23. West AB, Dawson VL, Dawson TM (2005) To die or grow: Parkinson's disease and cancer. Trends in Neurosciences 28: 348-352.
24. Jordan-Sciutto KL, Wang GJ, Murphey-Corb M, Wiley CA (2002) Cell cycle proteins exhibit altered expression patterns in lentiviral-associated encephalitis. Journal of Neuroscience 22: 2185-2195.
25. Hoeglinger GU, Breunig JJ, Depboylu C, Rouaux C, Michel PP, et al. (2007) The pRb/E2F cell-cycle pathway mediates cell death in Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 104: 3585-3590.
26. Yang Y, Herrup K (2005) Loss of neuronal cell cycle control in ataxiatelangiectasia: A unified disease mechanism. Journal of Neuroscience 25: 2522-2529.
27. Mitchell DJ, Kim DT, Steinman L, Fathman CG, Rothbard JB (2000) Polyarginine enters cells more efficiently than other polycationic homopolymers. Journal of Peptide Research 56: 318-325.
28. Morris MC, Chaloin L, Heitz F, Divita G (2000) Translocating peptides and proteins and their use for gene delivery. Current Opinion in Biotechnology 11: 461-466.
29. Li FZ, Ambrosini G, Chu EY, Plescia J, Tognin S, et al. (1998) Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 396: 580-584.
30. del Rio MJ, Velez-Pardo C (2004) The hydrogen peroxide and its importance in Alzheimer's and Parkinson's disease. Current Medicinal Chemistry - Central Nervous System Agents 4: 279-285.
31. Johannsen P, Velander G, Mai J, Thorling EB, Dupont E (1991) Glutathione peroxidase in early and advanced Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 54: 679-682.
32. Damier P, Hirsch EC, Zhang P, Agid Y, Javoyagid F (1993) Glutathioneperoxidase, glial-cells and parkinsons-disease. Neuroscience 52: 1-6.
33. Baratchi S, Kanwar RK, Khoshmanesh K, Vasu P, Ashok C, et al. (2009) Promises of Nanotechnology for Drug Delivery to Brain in Neurodegenerative Diseases. Current Nanoscience 5: 15-25.